Searched for
DRL TARGET
Analysts fret about DRL's prospects, slash targetsThe Hyderabad-based pharma major was the biggest loser on the bourses with trading volume rising nearly 10 times after a majority of the an...12 May, 2023, 06.11 AM IST- Dr Reddy's tumbles 7% post Q4 results! Here's what brokerages recommendDr Reddy's Laboratories reported an 890% YoY surge in March quarter profit at Rs 960.1 crore but shares tumbled nearly 7% to Rs 4,545 in Th...11 May, 2023, 11.25 AM IST
- What CLSA says on Lupin; Morgan Stanley on DRL, Godrej ConsumerIn the case of DRL, Morgan Stanley said that the drug maker continued to deliver granular growth and that the growth trend should continue ...20 May, 2022, 11.20 AM IST
- Buy Dr. Reddy's Laboratories, target price Rs 6400: Centrum BrokingDr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 87734.71 Crore) operating i...18 May, 2021, 11.49 AM IST
- Dr Reddy’s Lab shares up post Q1 results; should you invest?Global brokerage firm CLSA maintained ‘Buy’ on DRL with a target price of Rs 3,330.30 Jul, 2019, 10.30 AM IST
- DRL surges; company announces strategic alliance with BiocodexBiocodex has announced a change in partnership from October 1, giving complete rights to DRL for promotion and distribution of its products...04 Nov, 2015, 12.28 PM IST
- Sell DRL Ltd with a target of Rs 2510: Sandeep WagleDRL Ltd is a ‘SELL’ call with a target of Rs 2510 and a stop loss of Rs 2690.27 Mar, 2014, 10.12 AM IST
- Brokerages raise price target on Dr Reddy's to as high as Rs 2,720 on FDA nodBrokerages see the FDA approval to Dr Reddy’s Laboratories (DRL) for generic Vidaza as a positive for the company.18 Sep, 2013, 12.29 PM IST
- Brokerage views on Dr Reddy’s, Jindal Steel, IT sector, Bajaj AutoRead on to know what brokerages have to say about select stocks that are expected be in action today:21 Sep, 2012, 09.48 AM IST
- Dr Reddy's Laboratories bets big on biosimilars, eyes regulated marketsHyderabad-based Dr Reddy's Laboratories is betting big on the biosimilars segment and expects to enter developed markets soon.18 Jul, 2012, 08.45 PM IST
- ICICI Securities retains buy reating on Dr Reddy's LaboratoriesICICI Securities (I-Sec) has retained its 'buy' rating on pharma major Dr Reddy's Laboratories, with a price target of Rs 495.21 Mar, 2009, 02.20 AM IST
- Citigroup assigns 'hold' rating to Dr Reddy's LaboratoriesCitigroup has assigned a ‘hold’rating to Dr Reddy’s Laboratories (DRL) with a price target of Rs 547.18 Mar, 2009, 07.40 AM IST
- Analyst's Pick: Dr Reddy's LaboratoriesCitigroup recommends 'Hold' rating on Dr Reddy’s Laboratories with a target price of Rs 547.16 Mar, 2009, 05.01 AM IST
- Dr Reddy's set for global acquisitions to boost salesDRL is looking at acquisitions in areas such as branded formulations, generics and custom pharma services in US and other mkts. Night club ...07 May, 2008, 01.27 AM IST
- Dr Reddy’s Laboratories finetunes US generics planThe company, which has plans to file at least 20 Abbreviated New Drug Applications every year with the US FDA, plans to selectively file su...05 Nov, 2007, 01.29 AM IST
- DRL defends Boniva copy in the USPharma major Dr Reddy's defends its move to seek the rights to market the generic version of drug Boniva in the US.27 Sep, 2007, 04.25 AM IST
- DRS group of cos buys 98% stake in DRLHyderabad-based household transport unit, DRS Group of Companies - that owns Agarwal Packers and Movers - has acquired 98 per cent stake in...05 Jul, 2006, 05.47 PM IST
Load More
